Home / Inspections / 1216222

FDA Inspection 1216222 — RCHP Billings-Missoula, LLC.

RCHP Billings-Missoula, LLC. — FEI 1770743

The FDA completed an inspection of RCHP Billings-Missoula, LLC. on August 1, 2023 in Missoula, MT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 1, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Missoula, MT (United States)

Facility

Other inspections at this facility

  • 1283792 (NAI Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1064586 (NAI Thu Jul 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 975852 (NAI Wed Jun 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 881175 (NAI Wed May 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources